INDOCO vs VIYASH: Stock Comparison

Indoco Remedies Limited vs Viyash Scientific Ltd

Live data: 22 July 2026, 2:52 PM IST • Source: NSE and company filings

Viyash Scientific Ltd is the larger company by market capitalisation. Indoco Remedies Limited shows a lower P/E, a higher dividend yield and faster revenue growth, while Viyash Scientific Ltd shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Indoco Remedies Limited and Viyash Scientific Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, INDOCO is more favourable on 4 of 13 scored metrics and VIYASH on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
VIYASH is the larger company
₹11,242 Cr vs ₹2,160 Cr
P/E Ratio
INDOCO has a lower P/E
-23.83x vs 65.27x
P/B Ratio
INDOCO has a lower P/B
2.41x vs 3.98x
EPS
VIYASH has higher earnings per share
₹4.06 vs ₹-10.71
Dividend Yield
INDOCO has a higher dividend yield
0.08% vs 0%
Revenue Growth (TTM YoY)
INDOCO has faster revenue growth
21.9% vs 0%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
129% vs 21.9%
Qtr Profit Growth
VIYASH has stronger quarterly profit growth
455% vs 39%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDOCOVIYASH
SectorHealthcare
IndustryPharmaceuticals

Price

MetricINDOCOVIYASH
Live Price₹233.99₹257.5
Day Change-4.82%-2.89%
Volume71,68811.07 L
52-Week High₹336₹298
52-Week Low₹162.19₹178.13
Distance from 52W High-30.36%-13.59%

Valuation

MetricINDOCOVIYASH
Market Cap₹2,160 Cr₹11,242 Cr
P/E Ratio-23.83x65.27x
P/B Ratio2.41x3.98x
EPS₹-10.71₹4.06
Book Value₹111.55₹66.6
Dividend Yield0.08%0%

Growth

MetricINDOCOVIYASH
Revenue Growth (TTM YoY)21.9%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth21.9%129%
Qtr Profit Growth39%455%

Profitability & Leverage

MetricINDOCOVIYASH
ROE-9.42%11%
ROCE0.93%19%
Net Margin-5.31%6.57%
Operating Margin7.68%19.1%
Debt to Equity1.16x0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricINDOCOVIYASH
Promoter Holding58.86%0%
FII Holding1.27% 0.33 pp2.94% 0.22 pp
DII Holding17.68% 0.47 pp7.99% 0.63 pp
Public Holding22.04% 0.14 pp27.67% 0.3 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Indoco Remedies Limited and Viyash Scientific Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.